Picture of Taiko Pharmaceutical logo

4574 — Taiko Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Taiko Pharmaceutical -2020 parent results

Feb 12 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Dec 31, 2020    Mar 31, 2020   Dec 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             17.09           14.46                                
                                 (+45.8 pct)                             
  Operating          5.62            3.70                                
                                 (+91.2 pct)                             
  Recurring          5.47            3.52                                
                                 (+97.0 pct)                             
  Net                3.87            2.36                                
                                 (+76.8 pct)                             
  EPS             89.57 yen       55.31 yen                              
  EPS Diluted     89.21 yen       55.09 yen                              
  Ann Div         25.00 yen       50.00 yen      20.00 yen               
  -Q2 Div         7.00 yen        10.00 yen      7.00 yen                
  -Q4 Div         18.00 yen       40.00 yen      13.00 yen               
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T

Recent news on Taiko Pharmaceutical

See all news